Biohit Oyj
OMXH:BIOBV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biohit Oyj
OMXH:BIOBV
|
FI |
|
Vesync Co Ltd
HKEX:2148
|
US |
|
G M Breweries Ltd
NSE:GMBREW
|
IN |
|
Power Metals Corp
XTSX:PWM
|
CA |
|
W
|
Winshine Science Co Ltd
HKEX:209
|
HK |
|
Alliance Resource Partners LP
NASDAQ:ARLP
|
US |
|
Taiwan Shin Kong Security Co Ltd
TWSE:9925
|
TW |
|
K
|
K&K Superstore Southern PCL
SET:KK
|
TH |
|
FreeBit Co Ltd
TSE:3843
|
JP |
|
Belimo Holding AG
SIX:BEAN
|
CH |
Wall Street
Price Targets
BIOBV Price Targets Summary
Biohit Oyj
According to Wall Street analysts, the average 1-year price target for BIOBV is 3.57 EUR with a low forecast of 3.54 EUR and a high forecast of 3.68 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BIOBV's stock price target?
Price Target
3.57
EUR
According to Wall Street analysts, the average 1-year price target for BIOBV is 3.57 EUR with a low forecast of 3.54 EUR and a high forecast of 3.68 EUR.
What is Biohit Oyj's Revenue forecast?
Projected CAGR
17%
For the last 14 years the compound annual growth rate for Biohit Oyj's revenue is 15%. The projected CAGR for the next 3 years is 17%.
What is Biohit Oyj's Operating Income forecast?
Projected CAGR
12%
The compound annual growth rate of Biohit Oyj's operating income for the next 3 years is 12%.
What is Biohit Oyj's Net Income forecast?
Projected CAGR
10%
For the last 14 years the compound annual growth rate for Biohit Oyj's net income is -17%. The projected CAGR for the next 3 years is 10%.
